`

Larimar Therapeutics Inc

Biotechnology

Specialities :
Biotechnology and rare disease
Sign Up to View More
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$172.5M
size-icon Size
51 - 200
About Us
Org Charts
Employees
Buyer Intent
Tech Stack
Jobs

Frequently Asked Questions About Larimar Therapeutics Inc

What does Larimar therapeutics inc do?+

Larimar Therapeutics, Inc. (Nasdaq:LRMR), is a clinical-stage biotechnology company focused on developing treatments for complex rare diseases. The companys lead compound, CTI-1601, is currently being evaluated in a Phase 1 clinical program as a potential treatment for Friedreichs ataxia, a rare and progressive genetic disease. Larimar also plans to use its intracellular delivery platform to design other fusion proteins to target additional rare diseases characterized by deficiencies in intracellular bioactive compounds. For more information, please visit: https://larimartx.com

What are Larimar therapeutics inc's specialties? +

Biotechnology and rare disease

What is Larimar therapeutics inc's industry? +

Larimar therapeutics inc operates in the Biotechnology industry.

What is Larimar therapeutics inc's revenue? +

Larimar therapeutics inc's revenue is 11m - 100m

What is Larimar therapeutics inc's company size? +

Larimar therapeutics inc has 51 - 200 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Sign Up For Free
Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Sign Up For Free
Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.

Sign Up For Free